EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC 4.0

Cognitive impairment in children and adults with cerebrotendinous xanthomatosis: A French cohort study

Quentin Salardaine iD, Natalia Shor, Nicolas Villain, Frédérique Bozon, Maria Del Mar Amador, Clarisse Duchon, Nicolas Mélé, Manuel Schiff, Anaïs Brassier, Yann Nadjar

Journal of Inherited Metabolic Disease · 2024

DOI: 10.1002/jimd.12765 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Quentin Salardaine und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, AP-HP Sorbonne University, Pitié-Salpêtrière University Hospital, Paris, France. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Xanthomatosis, Cerebrotendinous. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebrotendinous xanthomatosis is a rare and treatable metabolic disorder related to the accumulation of cholestanol. This disorder is primarily associated with motor and cognitive impairments, although the latter has not been extensively characterized. The objectives of this work were to define the cognitive profile found in cerebrotendinous xanthomatosis patients, investigate the progression of cognitive impairment over time, and search for radio‐clinical correlations. Through a multicentric chart review study, we collected cognitive and radiological data from nine children and eighteen adults with genetically proven cerebrotendinous xanthomatosis. We performed a volumetric and morphological analysis of the brain magnetic resonance imaging. In our cohort, 44% (4/9) of children and 78% (14/18) of adults exhibited cognitive impairment that can be severe. The study revealed a significant impairment in various cognitive domains, specifically executive, attentional, language, and visuo‐spatial. Among adults, 16% (3/18) developed dementia after age 50. These three patients had delayed chenodeoxycholic acid treatment and important cerebral atrophy. Besides these three cases of late‐onset cognitive decline, Mini‐Mental State Evaluation was generally stable, suggesting cognitive impairment due to a neurodevelopmental disorder and persisting in adulthood. Cognitive impairment was less common in children, possibly related to early chenodeoxycholic acid treatment in our cohort. The severity of magnetic resonance imaging abnormalities did not predict cognitive impairment in patients. Overall, in cerebrotendinous xanthomatosis, cognitive impairment can be severe and mainly neurodevelopmental. Early chenodeoxycholic acid treatment might be associated with a reduced risk of cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionXanthomatosis, CerebrotendinousAdolescentAdultAgedChildFemaleHumansMaleMiddle AgedYoung AdultBrainChenodeoxycholic AcidCholestanolCohort StudiesFranceMagnetic Resonance Imaging

Stichwörter der Autor:innen

MMSEcerebrotendinous xanthomatosiscognitiondementianeuropsychological tests

Substanzen

Chenodeoxycholic AcidCholestanol

Autor:innen und Institutionen

  • Neurology Department, AP-HP Sorbonne University, Pitié-Salpêtrière University Hospital, Paris, France.
  • Neuroradiology Department, Pitié-Salpêtrière University Hospital, AP-HP, Sorbonne University, Paris, France.
  • Institut du Cerveau - ICM, Sorbonne Université, INSERM U1127, CNRS 7225, Paris, France.
  • Neurology Department, National Reference center ALS, Pitié-Salpêtrière University Hospital, AP-HP Sorbonne University, Paris, France.
  • Inherited Metabolic Disease Department and National Reference Centre for Inherited Metabolic diseases, Necker Hospital, AP-HP Centre-Paris University, Paris, France.
  • Neurology Department, GHU Paris Psychiatrie et Neurosciences, Université Paris Cité, Sainte-Anne Hospital, Paris, France.

ORCID-Profile: Quentin Salardaine

Zitieren

APA

Salardaine, Q., Shor, N., Villain, N., Bozon, F., Amador, M. D. M., Duchon, C., Mélé, N., Schiff, M., Brassier, A., & Nadjar, Y. (2024). Cognitive impairment in children and adults with cerebrotendinous xanthomatosis: A French cohort study. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12765

Vancouver

Salardaine Q, Shor N, Villain N, Bozon F, Amador MDM, Duchon C, et al. Cognitive impairment in children and adults with cerebrotendinous xanthomatosis: A French cohort study. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12765

BibTeX
@article{Salardaine2024,
  author = {Salardaine, Quentin and Shor, Natalia and Villain, Nicolas and Bozon, Frédérique and Amador, Maria Del Mar and Duchon, Clarisse and Mélé, Nicolas and Schiff, Manuel and Brassier, Anaïs and Nadjar, Yann},
  title = {Cognitive impairment in children and adults with cerebrotendinous xanthomatosis: A French cohort study},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  doi = {10.1002/jimd.12765}
}
Kostenlos starten →